VSTM - Verastem Inc logo

VSTM

Verastem Inc

Rev โ€”top 1%10Y
Hold

Verastem Inc develops and commercializes biopharmaceuticals targeting RAS/MAPK pathway-driven cancers. Its key products include Avutometinib and Defactinib, designed to inhibit critical signaling pathways in cancer cells and improve treatment outcomes.

โš•๏ธ Healthcare NASDAQ Listed 2012 $ USD
$1,000 invested 10 years ago โ†’$446today

Score Overview

1 Year
Score
Net Growth7.41%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth60.40%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.5
Net Growth-172.41%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth24x
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-432.27%
Net Trend20%
Net Income Consistency
Rev Growthโ€”
Rev Trend60%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-4x
Net Trend21%
Net Income Consistency
Rev Growthโ€”
Rev Trend43%
Revenue Consistency

See the full market ranking โ†’

Verastem Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 88M to $ 30M and net income went from -$ 67M to -$ 209M. Revenue increased in 4 of those 5 years; net income in 1.

Verastem Inc currently holds a 5-year HDB Score of 3.5 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 6.95โ€”
1 Year2025-08-12
$ 8.21-15.35%
5 Years2021-08-12
$ 34.56-79.89%
10 Years2016-08-12
$ 15.60-55.45%
All Time2012-01-27
$ 133.08-94.78%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 49M-$ 193M$ 181M
2025$ 30M-$ 209M$ 204M
2024$ 10M-$ 130M$ 88M
2023$ 0.00-$ 87M$ 137M
2022$ 2M-$ 73M$ 87M
2021$ 2M-$ 71M$ 100M
2020$ 88M-$ 67M$ 141M
2019$ 17M-$ 149M$ 75M
2018$ 26M-$ 72M$ 249M
2017$ 0.00-$ 67M$ 86M
2016$ 0.00-$ 36M$ 80M
2015$ 0.00-$ 57M$ 110M
2014$ 0.00-$ 53M$ 92M
2013$ 0.00-$ 41M$ 101M
IPO2012$ 0.00-$ 31M$ 56M

Explore beyond VSTM

You're looking at Verastem Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies